Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;56(9):4988-9.
doi: 10.1128/AAC.01201-12. Epub 2012 Jul 2.

Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance

C M Gant, A W Rosingh, J L López-Hontangas, M van der Heijden, F González-Morán, J J E Bijlsma, E Canton; RedMiva (Network of Microbiological Vigilance of Comunidad Valenciana)

Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance

C M Gant et al. Antimicrob Agents Chemother. 2012 Sep.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
(A) Erythromycin, (B) penicillin, and (C) levofloxacin susceptibility organized by serotype. Only vaccine serotypes and serotypes with at least one nonsusceptible strain are shown. Resistance to all three antibiotics was mostly seen in serotype 19A. Furthermore, erythromycin resistance was predominantly seen in serotypes 6A, 14, 19F, and 24B, penicillin intermediate resistance was predominately seen in serotype 4, and levofloxacin resistance was frequently seen in serotype 7F. White, susceptible; gray, intermediate resistant; black, resistant.
See this image and copyright information in PMC

References

    1. Ardanuy C, et al. 2009. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin. Infect. Dis. 48:57–64 - PubMed
    1. Dagan R. 2009. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. Infect. 15(Suppl 3):16–20 - PubMed
    1. Dirección General de Salúd Publica 2009. Enfermedad neumocócica invasora Informe 2008. Dirección General de Investigación y Salud, PúblicaGeneralitat Valenciana, Valencia, Spain: http://www.socvaped.org/pdf/docs/neumococica.pdf
    1. Isaacman DJ, McIntosh ED, Reinert RR. 2010. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int. J. Infect. Dis. 14:e197–e209 - PubMed
    1. Kadioglu A, Weiser JN, Paton JC, Andrew PW. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288–301 - PubMed

Publication types

MeSH terms